Document is current
Any future updates will be listed below
-
Authors
Dhrif, Omar https://orcid.org/0000-0002-1827-0311
Lahmar, Wided https://orcid.org/0000-0002-0948-6719
Achour, Taysir Ben https://orcid.org/0000-0003-1326-3689
Lohse, Anne https://orcid.org/0000-0002-6188-9304
Samson, Maxime https://orcid.org/0000-0002-6547-232X
- License Information
-
More Information
Article History
Received: 12 August 2025
Accepted: 24 September 2025
First Online: 23 October 2025
Declarations
:
: MS: AbbVie consulting fees, AstraZeneca consulting fees, argenx consulting fees, AstraZeneca consulting fees, Boehringer Ingelheim consulting fees, Fresenius Kabi consulting fees, GSK consulting fees, Novartis consulting fees and research grant, Roche–Chugai consulting fees, CSL Vifor Pharma consulting fees.
